Bcg Vaccine Ajv 1 ml Injection.

Indication

Prevention of tuberculosis in high-risk populations, particularly in infants and young children.

Dosage (summary)

Administer 1 ml intradermally, typically given at birth or as soon as possible after birth, with a second dose if indicated.

Onset of Action / Duration

The immune response develops within 2 to 3 weeks after vaccination.

Special Populations

• Infants
• Immunocompromised patients
• Individuals with a history of allergic reactions to components of the vaccine

Pregnancy & Breastfeeding

The vaccine is generally considered safe during pregnancy; however, it should be administered only if the benefits outweigh the risks. Caution is advised during lactation.

Key Drug Interactions

• Live vaccines may have reduced efficacy if administered simultaneously or within a short interval.
• Immunosuppressive therapies may reduce the effectiveness of the vaccine.

Contraindications

• Severe allergic reaction to any component of the vaccine.
• Active tuberculosis infection.
• Severe immunodeficiency (e.g., HIV with low CD4 count).

Common side effects

• Local reactions at the injection site (e.g., redness, swelling, tenderness)
• Fever
• Lymphadenopathy
• Rarely, systemic allergic reactions

Counselling Points

• Inform caregivers about the importance of vaccination in preventing tuberculosis.
• Advise on potential side effects and when to seek medical attention.
• Encourage completion of the vaccination schedule as recommended.